The combination of trimethoprim (TMP)-sulfamethoxazole (SMX) (T/S) has been employed for therapy of patients colonized with oxacillin-resistant Staphylococcus aureus; however, the efficacy of such therapy is uncertain, and the development of resistance may complicate treatment (2, 5, 7) . A factor that may contribute to therapeutic failure and to the emergence of resistance is the relatively low concentrations of SMX attained in body fluids and secretions, with reported levels rarely achieving 25% of attainable values in serum (12) . Previous studies have demonstrated a reduced occurrence of TMP resistance in previously susceptible organisms when TMP is combined with a sulfonamide, such as SMX (6) . Dapsone (DAP) has also been shown to have activity against gram-positive organisms (1) and, unlike SMX, may achieve concentrations in skin and other tissues 1.5 to 3.0 times peak values in serum (3, 4, 11) . For this reason, we evaluated the in vitro activity of DAP with and without TMP against gram-positive cocci, specifically oxacillin-resistant S. aureus, and compared this with the activity of SMX.
(This study was presented in part at the 28th Interscience (9) was used to determine susceptibilities to TMP, DAP, and SMX alone and to the combinations of T/S and TMP-DAP (T/D). Disk diffusion susceptibilities (8) for T/S were determined prior to the study so that isolates with a range of susceptibilities to this combination could be se- (5% final volume). Final concentrations for TMP were 0.016 to 256 ,ug/ml, for SMX they were 4.0 to 2,048 ,ug/ml, and for DAP they were 4.0 to 1,024 ,g/ml. T/S was tested at the fixed ratio of 1:19; T/D was tested at both the 1:19 and 1:1 ratios. This latter ratio was chosen to reflect achievable levels in serum with standard oral dosing for each drug (11, 12) . Final concentrations for T/D (1:1) were 0.016 to 256 ,ug/ml, and for T/S and T/D at 1:19 ratios final concentrations were 0.008 to 32 and 0.008 to 64 ,g/ml, respectively, expressed as the TMP concentration. S. aureus ATCC 29213, Streptococcus (Enterococcus) faecalis ATCC 29212, and Escherichia coli ATCC 25922 were included as controls.
The MICs of TMP occurred in a bimodal distribution, with clustering at 0.062 to 1.0 and 64 to 256 ,ug/ml (Fig. 1) . A similar bimodal clustering occurred for TMP when it was combined with either SMX or DAP. No TMP-resistant strain (MIC > 1.0 ,ug/ml) became susceptible with the addition of either DAP or SMX. All strains that were T/S susceptible by disk diffusion were susceptible to TMP by microdilution, with an MIC of '1.0 ,ug/ml, whereas the MICs for all strains that were resistant to T/S by disk diffusion were .64 p.g/ml.
For those isolates with intermediate T/S disk diffusion susceptibility, TMP microdilution MICs were widely scattered, ranging from 0.062 to >256 ,ug/ml. There were wide susceptibility ranges for SMX and DAP. DAP MICs were generally one dilution higher than those of SMX. No strain was susceptible to DAP alone when a breakpoint of 4 ,g/ml was used, while 13 of 60 strains (22%) were susceptible to SMX with a breakpoint of 64 jig/ml. T/S and T/D had virtually identical activities at the ratio of 1:19 (Fig. 1) . T/D at the ratio of 1:1 was less active, with MICs that were one to three dilutions higher than those of T/D and T/S at the 1:19 ratio. However, all isolates susceptible to T/S at the 1:19 ratio were susceptible to T/D at the 1:1 ratio. The relative susceptibilities to the fixed concentrations are presented in a scattergram (Fig. 2) .
Previous studies indicated that DAP might have greater activity against gram-positive cocci than SMX (1). We did not find that to be the case for oxacillin-resistant S. aureus. The combination of T/D had in vitro activity that was comparable but not superior to that of T/S. No 
